Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
Circulation
|
September 8, 1999
Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty
A Lafont, E Durand, J L Samuel, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 25, 2021
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
Arnaud Bayle, N Droin, B Besse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
B Besse, C Massard, V Haddad, et al.
Pediatric Blood & Cancer
|
August 19, 2014
Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature
J Rod, D Orbach, C Verité, et al.
Revue Des Maladies Respiratoires
|
March 8, 2014
[Management of the cardiovascular complications of treatment in thoracic oncology]
S Ederhy, A Hollebecque, N Haddour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?
C Massard, A Plantade, M Gross-Goupil, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
E G C Brain, K Rezai, S Weill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
J-C Soria, A Mauguen, M Reck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 2, 2025
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors
S V Liu, R Dziadziuszko, S Viteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
P Schöffski, B Besse, T Gauler, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
Circulation
|
September 8, 1999
Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty
A Lafont, E Durand, J L Samuel, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 25, 2021
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
Arnaud Bayle, N Droin, B Besse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
B Besse, C Massard, V Haddad, et al.
Pediatric Blood & Cancer
|
August 19, 2014
Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature
J Rod, D Orbach, C Verité, et al.
Revue Des Maladies Respiratoires
|
March 8, 2014
[Management of the cardiovascular complications of treatment in thoracic oncology]
S Ederhy, A Hollebecque, N Haddour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?
C Massard, A Plantade, M Gross-Goupil, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
E G C Brain, K Rezai, S Weill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
J-C Soria, A Mauguen, M Reck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 2, 2025
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors
S V Liu, R Dziadziuszko, S Viteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
P Schöffski, B Besse, T Gauler, et al.
Page
of 14